/ Side by side
Octreotide vs Lanreotide
A neutral, side-by-side look at Octreotide and Lanreotide: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Octreotide
Sandostatin · Octreotide acetate
Full profile →Lanreotide
Somatuline Depot · Lanreotide acetate
Full profile →| Attribute | Octreotide | Lanreotide |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Half-life | ~1.7-1.9 h, injection | ~23-30 days, extended-release subcutaneous |
| Common vial | Varies | 60, 90, 120 mg |
| Reference | Verified | Verified |
What is Octreotide?
A synthetic somatostatin analog approved for acromegaly and for symptoms associated with certain neuroendocrine tumours. It suppresses growth hormone release, the opposite direction to the secretagogues in this category.
Sources
- FDA label: octreotide acetate injection (ANDA 075957)
What is Lanreotide?
A long-acting somatostatin analog approved for acromegaly and for certain neuroendocrine tumours. Its extended-release formulation gives it one of the longest dosing intervals of any peptide in this library.
Sources
- FDA label: lanreotide acetate injection (NDA 215395)
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.